Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC

BackgroundDisulfidptosis is a newly discovered form of cell death associated with tumorigenesis, particularly under oxidative stress and metabolic disorder conditions. Currently, the biological mechanisms of disulfidptosis-related genes (DRGs) in head and neck squamous cell carcinoma (HNSCC) remain...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haotian Qin, Juan Xu, Yaohang Yue, Meiling Chen, Zheng Zhang, Panpan Xu, Yan Zheng, Hui Zeng, Jian Weng, Jun Yang, Fei Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	disulfidptosis head and neck squamous cell carcinoma prognostic signatures bioinformatics analysis immunotherapy response
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1456649/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)

Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC
by: Xiaoqin Luo, et al.
Published: (2025-02-01)

Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2025-01-01)

Bioinformation study of immune microenvironment characteristics of disulfidptosis-related subtypes in ovarian cancer and prognostic model construction
by: Ying Zhou, et al.
Published: (2025-01-01)

The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study
by: Min Ouyang, et al.
Published: (2025-01-01)

Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in breast cancer
by: Xiaozhou Yang, et al.
Published: (2025-01-01)

Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes
by: Chuankuo Zhang, et al.
Published: (2025-01-01)

Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
by: Mingjie Wei, et al.
Published: (2025-01-01)

Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma
by: Xuechen Wu, et al.
Published: (2025-02-01)

Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
by: Wenxue Wu, et al.
Published: (2025-01-01)

Prognostic signature based on mitochondria- and angiogenesis-related genes associated with immune microenvironment of multiple myeloma
by: Dai Zhang, et al.
Published: (2025-12-01)

Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
by: Yuying Zhao, et al.
Published: (2024-12-01)

Identification of a mitophagy-related gene signature for predicting overall survival and response to immunotherapy in rectal cancer
by: Jian Yang, et al.
Published: (2025-01-01)

Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC
by: Yulin Zhang, et al.
Published: (2025-02-01)

Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure
by: Linna Zhao, et al.
Published: (2025-01-01)

Expression and clinical significance of disulfidptosis-related LncRNA in gastric cancer
by: CHU Yudan, SUN Haidong, CUI Ran, ZHENG Hong
Published: (2024-09-01)

A machine learning model and identification of immune infiltration for chronic obstructive pulmonary disease based on disulfidptosis-related genes
by: Sijun Li, et al.
Published: (2025-01-01)

Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01)

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01)

Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
by: Yifu Shu, et al.
Published: (2025-01-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2023-07-01)

A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis
by: Nasibeh Khayer, et al.
Published: (2025-01-01)

Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)

Identifying disulfidptosis-related biomarkers in epilepsy based on integrated bioinformatics and experimental analyses
by: Sijun Li, et al.
Published: (2025-02-01)

A study protocol for individualized prognostic counselling in the palliative phase
by: Boyd Noël van den Besselaar, et al.
Published: (2025-01-01)

Nomogram-derived immune-inflammation-nutrition score could act as a novel prognostic indicator for patients with head and neck squamous cell carcinoma
by: Wen-Yan Wang, et al.
Published: (2025-01-01)

Catalysts of change: Immunotherapy's frontier in oral oncology
by: Shyamaladevi Babu, et al.
Published: (2024-09-01)

Targeting ferroptosis for improved radiotherapy outcomes in HPV‐negative head and neck squamous cell carcinoma
by: Joo Kyung Noh, et al.
Published: (2025-02-01)

Identification and validation of glucose metabolism-related gene signature in endometrial cancer
by: Juan Jiang, et al.
Published: (2025-01-01)

CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis
by: Hong-Fei Yao, et al.
Published: (2025-01-01)

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)

A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma
by: Anshun Wu, et al.
Published: (2024-12-01)

Comprehensive bioinformatic profiling of matrix metalloproteinases and their inhibitors: Expression and interaction patterns in head and neck cancer toward predictive biomarkers and personalized therapies
by: Rishaba Byju, et al.
Published: (2024-09-01)

Fatty acid metabolism-related signature suggests an oncogenic role of TEKT1 in endometrial cancer
by: Zhikai Xiahou, et al.
Published: (2025-01-01)

Adaptive extraction method of network application signatures
by: Bian-qin WANG, et al.
Published: (2013-04-01)

NDUFA11 may be the disulfidptosis-related biomarker of ischemic stroke based on integrated bioinformatics, clinical samples, and experimental analyses
by: Sijun Li, et al.
Published: (2025-01-01)

Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature
by: Ting Yan, et al.
Published: (2025-01-01)

Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer
by: Longpeng Li, et al.
Published: (2025-01-01)